Dimensional Fund Advisors
TCRT icon

Dimensional Fund Advisors’s Alaunos Therapeutics TCRT Stock Holding History

Dimensional Fund Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,271
Closed -$8.88K – 3386
2024
Q2 		$8.88K Sell
1,271
-28
-2% -$334 ﹤0.01% 3369
2024
Q1 		$23.5K Buy
+1,299
New +$26K ﹤0.01% 3360
2023
Q3 		– Sell
-603
Closed -$46.1K – 3504
2023
Q2 		$46.1K Sell
603
-6
-1% -$485 ﹤0.01% 3411
2023
Q1 		$57.5K Hold
609
– – ﹤0.01% 3371
2022
Q4 		$60 Hold
609
– – ﹤0.01% 3380
2022
Q3 		$157K Sell
609
-93
-13% -$27K ﹤0.01% 3277
2022
Q2 		$130K Hold
702
– – ﹤0.01% 3294
2022
Q1 		$69K Hold
702
– – ﹤0.01% 3429
2021
Q4 		$115K Buy
702
+8
+1% +$1.76K ﹤0.01% 3420
2021
Q3 		$190K Sell
694
-441
-39% -$135K ﹤0.01% 3356
2021
Q2 		$450K Sell
1,135
-15
-1% -$7K ﹤0.01% 3183
2021
Q1 		$621K Buy
1,150
+957
+496% +$596K ﹤0.01% 3100
2020
Q4 		$73K Buy
+193
New +$76.7K ﹤0.01% 3296
2015
Q4 		– Sell
-102
Closed -$138K – 3343
2015
Q3 		$138K Sell
102
-38
-27% -$62.7K ﹤0.01% 3276
2015
Q2 		$252K Buy
+140
New +$217K ﹤0.01% 3225

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return

Dimensional Fund Advisors's TCRT Position: Q3 2024 in Review

Dimensional Fund Advisors sold out of Alaunos Therapeutics (TCRT) in Q3 2024, closing a stake of 1,271 shares — an estimated $8.88K sold.

Dimensional Fund Advisors first reported a position in TCRT in Q2 2015 and held it in 15 quarters. The position peaked at $621K in Q1 2021. 29 funds tracked by Wall St. Rank hold TCRT as of Q3 2024.

  • Dimensional Fund Advisors reported no remaining Alaunos Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,271 Alaunos Therapeutics shares in Q3 2024, an estimated $8.88K.
  • Dimensional Fund Advisors first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 15 quarters.
  • Dimensional Fund Advisors's Alaunos Therapeutics position peaked at $621K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2024.

Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.